FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.

ELSI SERVICES & RESEARCH

RESEARCH

We conduct research relating to ethical, legal and societal issues (ELSI). This is fundamental to staying up to date with and contributing knowledge to our services and training.

 

SERVICE

We support the biobanking and life science RI communities by facilitating compliance with regulatory requirements and best practice standards.

TRAINING

We provide training and workshops on ELSI issues such as Data Protection Impact Assessment (DPIA), ethical compliance and social engagement, among others.

The ELSI Team

VISION

We deliver reliable, practical and sustainable services based on state-of-the-art research for the immediate benefit of the life sciences community by setting standards, promoting best practices or enabling a sustainable platform for internal and public knowledge exchange. To date, our expertise has been requested in more than 30 projects.

EXCELLENCE & EXPERTISE

Over the past decade, our interdisciplinary team has developed several interrelated lines of expertise on ethical, legal, and societal implications (ELSI) relevant for the biobanking and life sciences community.

To ensure excellence in providing guidance on ethical, legal and societal implications (ELSI), we operate on the basis of a federated model, in partnership with a network of experts from academia and practice from across the Headquarters, the National Nodes and project partners. Focus areas are recognised in collaboration with European and international ELSI experts and based on user needs identified in projects or ELSI Helpdesk requests coming from patient advocacy groups, industry partners or biobankers.

Why ELSI matters!


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept